EUVIMEDEUVIMED entdecken
Crossref

Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study

Himanshu Dandu, Naveen Kumar, Neeraj Kumar, Hardeep Singh Malhotra, Vikas Prabhu, Vipin Raj Bharti, Prashant Gupta, Geeta Yadav, Veerendra Verma

Mycopathologia · 2024

DOI: 10.1007/s11046-024-00859-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mycopathologia, 2024. Verfasst von Himanshu Dandu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, King George's Medical University, Lucknow, India. Hauptthemen laut MEDLINE: Itraconazole, Mucormycosis, Amphotericin B, Antifungal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: During the COVID-19 pandemic-associated mucor epidemic, acute antifungal drug shortage necessitated the exploration of other antifungals based on culture sensitivity. Itraconazole is a cheap, safe, and effective antifungal in sensitive cases. METHODOLOGY: We enrolled itraconazole-sensitive COVID-19-associated mucormycosis during the mucormycosis pandemic. After the intensive phase course of liposomal amphotericin B, Itraconazole was offered in susceptible cases during the maintenance phase along with standard of care. These patients were clinically and radiologically followed for 6 months. RESULTS: We enrolled 14 patients (Male: Female-11:3) of Rhino-orbito-cerebral mucormycosis (ROCM) which included 12 diabetics. All patients had facial swelling, orbital swelling, visual impairment, and headache. MRI showed involvement of bilateral sinus (10/14), orbital extension (13/14), cavernous sinus (5/14), cerebral part of the internal carotid artery (3/14), and brain infarcts (4/14). All 14 patients showed sensitivity to Itraconazole with 12 having minimum inhibitory concentration (MIC) ≤ 1 μg/ml and 2 having MIC ≤ 2 μg/ml. Follow-up at 6 months showed clinical improvement in the majority (11/14) and radiological improvement in six out of seven scanned patients. CONCLUSION: Our study shows the potential therapeutic role of oral Itraconazole in ROCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ItraconazoleMucormycosisAmphotericin BAntifungal AgentsRhizopus oryzaeHumansMaleFemaleMiddle AgedAdultMicrobial Sensitivity TestsCOVID-19AgedDrug Therapy, CombinationTreatment Outcome

Stichwörter der Autor:innen

Amphotericin BAntifungalsCOVID-19DiabetesItraconazoleMucormycosisPandemicRhino-orbito-cerebral mucormycosis

Substanzen

ItraconazoleAmphotericin BAntifungal Agentsliposomal amphotericin B

Autor:innen und Institutionen

  • Department of Medicine, King George's Medical University, Lucknow, India.
  • Department of Neurology, King George's Medical University, Lucknow, India. drneeraj2903@gmail.com.
  • Department of Neurology, King George's Medical University, Lucknow, India.
  • Department of Microbiology, King George's Medical University, Lucknow, India.
  • Department of Pathology, King George's Medical University, Lucknow, India.
  • Department of Otorhinolaryngology, King George's Medical University, Lucknow, India.

Zitieren

APA

Dandu, H., Kumar, N., Kumar, N., Malhotra, H. S., Prabhu, V., Bharti, V. R., Gupta, P., Yadav, G., & Verma, V. (2024). Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study. Mycopathologia. https://doi.org/10.1007/s11046-024-00859-w

Vancouver

Dandu H, Kumar N, Kumar N, Malhotra HS, Prabhu V, Bharti VR, et al. Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study. Mycopathologia. 2024. doi:10.1007/s11046-024-00859-w

BibTeX
@article{Dandu2024,
  author = {Dandu, Himanshu and Kumar, Naveen and Kumar, Neeraj and Malhotra, Hardeep Singh and Prabhu, Vikas and Bharti, Vipin Raj and Gupta, Prashant and Yadav, Geeta and Verma, Veerendra},
  title = {Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study},
  journal = {Mycopathologia},
  year = {2024},
  doi = {10.1007/s11046-024-00859-w}
}
Kostenlos starten →